Cannabidiol News March 19 2019
- $1.8 billion Altria, the maker of Marlboro, put $1.8 billion into Cronos Group
- $4 billion Constellation Brands, which produces Corona beer and dozens of other brands, invested nearly $4 billion in Canopy Growth
Kentucky’s resurgent hemp sector flexed more economic clout in 2018, with processors reporting sharply higher sales and farmers reaping more than twice as much income from their crop, the state’s agriculture commissioner said Monday. The state’s hemp processors reported $57.75 million in gross product sales last year, compared with $16.7 million in 2017, Kentucky Agriculture Commissioner Ryan Quarles said. Processors spent $23.4 million in capital improvements and employed a total of 459 people in 2018, he said. Processors paid Kentucky farmers $17.75 million for harvested hemp materials in 2018, up from $7.5 million the year before, Quarles said.
DALLAS, March 18, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC:KALY) (“KALY”) today announced Professor Jeffry Osbourn, Ph.D., from the University of Kentucky and the principal of Biomedical Science Research Group (BSRG), and KALY CEO Frederick Ferri met last week to coordinate a phase two study of a pilot treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates with cannabis extracts derived from Kali-Extracts patented cannabis extraction process. A report on the first primate study from Professor Jeffry Osbourn is coming soon. The primate study adds to the Kali-Extracts in vitro genomics study, previously announced, to evaluate the impact of its pharmaceutical grade cannabis extracts in combination with other therapies on COPD patients. The World Health Organization estimates 65 million people worldwide are afflicted with moderate to severe COPD and GlobalData forecasts that the COPD treatment market will reach $14.1 billion by 2025.
Scott Salisbury… $5,800.00 per kilo we have 20 kilos of Isolate on the ground. 253 221 9051.